-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2018 to Q2 2024.
- Reviva Pharmaceuticals Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$7.86M, a 32.9% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$36M, a 5.51% decline year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$39.3M, a 38.9% decline from 2022.
- Reviva Pharmaceuticals Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$28.3M, a 232% decline from 2021.
- Reviva Pharmaceuticals Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$8.52M, a 125% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)